Journal Logo

June 2007 - Volume 49 - Issue 6
pp: 337-418

Effects of p38 MAPK Inhibitor on Angiotensin II-Dependent Hypertension, Organ Damage, and Superoxide Anion Production

Bao, Weike; Behm, David J; Nerurkar, Sandhya S; More

Journal of Cardiovascular Pharmacology. 49(6):362-368, June 2007.

Caffeine Attenuates the Duration of Coronary Vasodilation and Changes in Hemodynamics Induced by Regadenoson (CVT-3146), a Novel Adenosine A2A Receptor Agonist

Zhao, Gong; Messina, Eric; Xu, Xiaobin; More

Journal of Cardiovascular Pharmacology. 49(6):369-375, June 2007.

Rosuvastatin Suppresses the Inflammatory Responses Through Inhibition of c-Jun N-terminal Kinase and Nuclear Factor-κB in Endothelial Cells

Kim, Yong Sook; Ahn, Youngkeun; Hong, Moon Hwa; More

Journal of Cardiovascular Pharmacology. 49(6):376-383, June 2007.

The PPARα Activator Fenofibrate Slows Down the Progression of the Left Ventricular Dysfunction in Porcine Tachycardia-Induced Cardiomyopathy

Brigadeau, François; Gelé, Patrick; Wibaux, Maud; More

Journal of Cardiovascular Pharmacology. 49(6):408-415, June 2007.


Improvement of Cardiac Function With Parecoxib, A Cyclo-oxygenase-2 Inhibitor, in a Rat Model of Ischemic Heart Failure

Abbate, Antonio; Salloum, Fadi N; Ockaili, Ramzi A; More

Journal of Cardiovascular Pharmacology. 49(6):416-418, June 2007.